Effect of impairment on health-related quality of life in people with multiple sclerosis: association of functional systems and EQ-5D-5L index values in a cross-sectional study

被引:0
作者
Schmidt, Richard [1 ]
Starke, Andreas [1 ]
Bednarz, Natalie [1 ]
Bergh, Florian Then [1 ]
机构
[1] Univ Leipzig, Med Fac, Dept Neurol, Liebigstr 20, D-04103 Leipzig, Germany
关键词
Quality of life; Multiple sclerosis; Impairment; Disability; Cognition; DISABILITY STATUS SCALE; IMPORTANT DIFFERENCE; COGNITIVE ASSESSMENT; PREVALENCE; INSTRUMENT; INSIGHTS; BURDEN; IMPACT; MOCA;
D O I
10.1007/s11136-025-03928-9
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
IntroductionMultiple sclerosis (MS) results in physical and cognitive impairments that negatively affect health-related quality of life (HRQoL). It is unknown to what extent the impact of MS-related impairments on HRQoL are reflected in the association of Expanded Disability Status Scale (EDSS) Functional Systems (FS) scores and EQ-5D-5L index values.MethodsThis cross-sectional, single-center cohort study recruited people with MS (pwMS) attending an outpatient clinic at a German university hospital. Impairment was assessed via FS scores during routine visits. HRQoL was measured with EQ-5D-5L index values. The association of each FS score with EQ-5D-5L index values and the additive effect of all FS on EQ-5D-5L index values was modeled with multivariate linear regression (MLR).ResultsAnalyzing 115 participants, unadjusted MLR of single FS revealed that brainstem, pyramidal, cerebellar, sensory, and cerebral/cognitive dysfunctions were significantly associated with lower HRQoL. In MLR of all FS adjusted for covariates, a one standard deviation decrease in cognitive function was significantly associated with a 6% reduction in HRQoL.ConclusionDysfunctions in FS contribute to a decrease in HRQoL. Cognitive dysfunction was identified to maintain negative association with HRQoL after adjustment for covariates, and routinely assessed FS scores appeared useful indicators to identify pwMS who may benefit from comprehensive cognitive evaluations. This study adds to the growing body of evidence emphasizing the crucial role of cognitive function in HRQoL of pwMS and highlights the need for effective screening and therapeutic strategies.
引用
收藏
页码:1773 / 1781
页数:9
相关论文
共 52 条
[1]   Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis [J].
Abdelhak, Ahmed ;
Antweiler, Kai ;
Kowarik, Markus C. ;
Senel, Makbule ;
Havla, Joachim ;
Zettl, Uwe K. ;
Kleiter, Ingo ;
Hoshi, Muna-Miriam ;
Skripuletz, Thomas ;
Haarmann, Axel ;
Stahmann, Alexander ;
Huss, Andre ;
Gingele, Stefan ;
Krumbholz, Markus ;
Selge, Charlotte ;
Friede, Tim ;
Ludolph, Albert C. ;
Overell, James ;
Koendgen, Harold ;
Clinch, Susanne ;
Wang, Qing ;
Ziemann, Ulf ;
Hauser, Stephen L. ;
Kumpfel, Tania ;
Green, Ari J. ;
Tumani, Hayrettin .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 81
[2]   Estimating the disutility of relapse in relapsing-remitting and secondary progressive multiple sclerosis using the EQ-5D-5L, AQoL-8D, EQ-5D-5L-psychosocial, and SF-6D: implications for health economic evaluation models [J].
Ahmad, Hasnat ;
Campbell, Julie A. A. ;
van der Mei, Ingrid ;
Taylor, Bruce V. V. ;
Xia, Qing ;
Zhao, Ting ;
Palmer, Andrew J. J. .
QUALITY OF LIFE RESEARCH, 2023, 32 (12) :3373-3387
[3]   Validity of the minimal assessment of cognitive function in multiple sclerosis (MACHMS) [J].
Benedict, Ralph H. B. ;
Cookfair, Diane ;
Gavett, Rebecca ;
Gunther, Mark ;
Munschauer, Frederick ;
Garg, Neeta ;
Weinstock-Guttman, Bianca .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2006, 12 (04) :549-558
[4]   Valuing health states for use in cost-effectiveness analysis [J].
Brazier, John .
PHARMACOECONOMICS, 2008, 26 (09) :769-779
[5]   Integration of Cognitive Impairment in the Expanded Disability Status Scale of 215 Patients with Multiple Sclerosis [J].
Brissart, Helene ;
Sauvee, Mathilde ;
Latarche, Clotilde ;
Dillier, Celine ;
Debouverie, Marc .
EUROPEAN NEUROLOGY, 2010, 64 (06) :345-350
[6]  
Calabrese P., 2004, Psychoneuro, V30, P384, DOI DOI 10.1055/S-2004-831083
[7]   Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia [J].
Campbell, Julie A. ;
Ahmad, Hasnat ;
Chen, Gang ;
van der Mei, Ingrid ;
Taylor, Bruce, V ;
Claflin, Suzi ;
Henson, Glen J. ;
Simpson-Yap, Steve ;
Laslett, Laura L. ;
Hawkes, Kirsty ;
Hurst, Carol ;
Waugh, Hilary ;
Palmer, Andrew J. .
QUALITY OF LIFE RESEARCH, 2023, 32 (02) :553-568
[8]  
Charvet L.E., 2015, J. Mult. Scler. (Foster City), V02, DOI [DOI 10.4172/2376-0389.1000135, 10.4172/2376-0389.1000135]
[9]   Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis [J].
Dagenais, Emmanuelle ;
Rouleau, Isabelle ;
Demers, Melanie ;
Jobin, Celine ;
Roger, Elaine ;
Chamelian, Laury ;
Duquette, Pierre .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2013, 40 (03) :410-415
[10]   Treatment and management of cognitive dysfunction in patients with multiple sclerosis [J].
DeLuca, John ;
Chiaravalloti, Nancy D. ;
Sandroff, Brian M. .
NATURE REVIEWS NEUROLOGY, 2020, 16 (06) :319-332